Originates increases pharma gelatin capacity
US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
TFC forms JV to boost DMSO output
Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production.
Mylan partners to create FOBs
Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market.
Caraco products seized by FDA
US Marshals have seized products from Caraco’s facilities in Michigan because of concerns over cGMP compliance, which has led to Sun Pharma withdrawing its financial guidance.
Nanoparticles used to stabilise proteins
Researchers have used nanoparticles to stabilise membrane proteins, allowing for detailed analysis of their structure and molecular functions that could help drug discovery.
Pressure to cut jobs feeds demand for more efficient equipment
Equipment that enables cosmetics and pharmaceutical companies to reduce headcount and save floor space is in high demand as pressure to cut costs mounts.
KBI rolls out PER.C6 service in US
US contract services firm KBI Biopharma has begun using the PER.C6 platform for cell line generation as part of its offering to meet growing demand for biomanufacturing services.
OctoPlus’ trial materials plant open for business
Dutch biopharmaceuticals producer OctoPlus has begun manufacturing operations at its new facility in Leiden, the Netherlands.
KV completes investigation; admits deficiencies
KV Pharmaceutical found deficiencies and instances of noncompliance during its internal investigation, which was launched in response to issues with the FDA and allegations of management misconduct.
Lilly’s CEO taking a role at Nike and Takeda’s illustrious global advisory board – People on the move
in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including Lilly’s CEO taking a role at Nike and Takeda’s illustrious global advisory board.
Sanyo claims H202 steralised incubator is industry first
Sanyo Biomedical and Environmental Solutions claims the H202 steralisation approach used by its Steisonic CxP MCO-19AIC(UVH) cell incubator system is an industry first and effective replacement for ethylene oxide (EtO).
Azopharma expands cytotoxics capacity
US contractor Azopharma has added new GMP quality cytotoxics and high-potency manufacturing capacity at its facility in Hollywood, South Florida in a bid to strengthen its position in the trial materials sector.
Biologics shift packaging growth areas
The world pharma packaging market is predicted to rise 5.3 per cent to more than $47bn (€33.3bn) in 2013, with increased use of biologics driving change.
FDA launches focus on transparency
Regulatory agencies are putting increased emphasis on transparency, with the FDA holding its first public meeting on the topic and the EMEA seeking feedback from citizens on its draft policy.
Solvay loses out on Dutch H1N1 vacc contract
Belgian drug and chemicals giant Solvay has lost out on a contract to supply the Dutch government with an H1N1 vaccine after it said it could not meet the production deadline.